BioCentury
ARTICLE | Clinical News

Sepracor regulatory update

November 14, 1994 8:00 AM UTC

SEPR received U.S. Patent No. 5,362,755 covering the use of R-albuterol, the single-isomer version of albuterol. Albuterol, a racemic Beta-2 agonist, had 1993 sales of $1.1 billion, SEPR said. ...